Brief: Relief Therapeutics Aviptadil To Be Included In NIH-Sponsored Clinical Trial In U.S.

MindMaze Therapeutics Holding SA

06/04/2021 06:07

April 6 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * NEURORX ANNOUNCES ZYESAMI™ (AVIPTADIL) HAS BEEN SELECTED
FOR
INCLUSION IN NIH-SPONSORED GLOBAL CLINICAL TRIAL TO INCLUDE
AVIPTADIL AND REMDESIVIR
    * ADDITIONAL INFORMATION WILL BE SUPPLIED BY NIH WHEN TRIAL
RANDOMIZES ITS FIRST PATIENTS.
    * PRIMARY ENDPOINT OF TRIAL WILL BE PARTICIPANT RECOVERY
FROM
RESPIRATORY FAILURE OVER 90 DAYS

Source text for Eikon:  ID:nPn7vhKRva 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))